These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7559730)

  • 21. [Functional role of IRF--family transcription factors].
    Tanaka N
    Tanpakushitsu Kakusan Koso; 2000 Jun; 45(9 Suppl):1551-9. PubMed ID: 10879133
    [No Abstract]   [Full Text] [Related]  

  • 22. IRF-1 as a negative regulator of cell proliferation.
    Romeo G; Fiorucci G; Chiantore MV; Percario ZA; Vannucchi S; Affabris E
    J Interferon Cytokine Res; 2002 Jan; 22(1):39-47. PubMed ID: 11846974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ectopic expression of interferon regulatory factor-1 potentiates granulocytic differentiation.
    Coccia EM; Stellacci E; Valtieri M; Masella B; Feccia T; Marziali G; Hiscott J; Testa U; Peschle C; Battistini A
    Biochem J; 2001 Dec; 360(Pt 2):285-94. PubMed ID: 11716756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Involvement of positive (IRF-1) and negative (IRF-2) transcription factors in the gene regulation of the type I interferon system].
    Watanabe N; Taniguchi T
    Tanpakushitsu Kakusan Koso; 1992 Oct; 37(14 Suppl):2813-22. PubMed ID: 1438857
    [No Abstract]   [Full Text] [Related]  

  • 25. Suppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1.
    Tanaka N; Ishihara M; Taniguchi T
    Cancer Lett; 1994 Aug; 83(1-2):191-6. PubMed ID: 8062214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of the IRF-1 transcription factor in antiviral responses to interferons.
    Kimura T; Nakayama K; Penninger J; Kitagawa M; Harada H; Matsuyama T; Tanaka N; Kamijo R; Vilcek J; Mak TW
    Science; 1994 Jun; 264(5167):1921-4. PubMed ID: 8009222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PU.1 and multiple IFN regulatory factor proteins synergize to mediate transcriptional activation of the human IL-1 beta gene.
    Marecki S; Riendeau CJ; Liang MD; Fenton MJ
    J Immunol; 2001 Jun; 166(11):6829-38. PubMed ID: 11359842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcription factors IRF-1 and IRF-2: linking the immune responses and tumor suppression.
    Taniguchi T
    J Cell Physiol; 1997 Nov; 173(2):128-30. PubMed ID: 9365509
    [No Abstract]   [Full Text] [Related]  

  • 29. IRF regulation of HIV-1 long terminal repeat activity.
    Battistini A; Marsili G; Sgarbanti M; Ensoli B; Hiscott J
    J Interferon Cytokine Res; 2002 Jan; 22(1):27-37. PubMed ID: 11846973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon regulatory factor 1 (IRF-1) mediates cell growth inhibition by transactivation of downstream target genes.
    Kirchhoff S; Schaper F; Hauser H
    Nucleic Acids Res; 1993 Jun; 21(12):2881-9. PubMed ID: 8332497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs.
    Thornton AM; Ogryzko VV; Dent A; Sharf R; Levi BZ; Kanno Y; Staudt LM; Howard BH; Ozato K
    J Immunol; 1996 Dec; 157(11):5145-54. PubMed ID: 8943426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the interferon regulatory factors (IRFs) in virus-mediated signaling and regulation of cell growth.
    Pitha PM; Au WC; Lowther W; Juang YT; Schafer SL; Burysek L; Hiscott J; Moore PA
    Biochimie; 1998; 80(8-9):651-8. PubMed ID: 9865487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Function, molecular structure and gene expression of interferons].
    Yoshida I; Azuma M
    Nihon Rinsho; 1992 Aug; 50(8):1845-53. PubMed ID: 1279237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility of IFN regulatory factor-1 and IFN consensus sequence binding protein-deficient mice to brucellosis.
    Ko J; Gendron-Fitzpatrick A; Splitter GA
    J Immunol; 2002 Mar; 168(5):2433-40. PubMed ID: 11859135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain.
    Nguyen H; Mustafa A; Hiscott J; Lin R
    Oncogene; 1995 Aug; 11(3):537-44. PubMed ID: 7630638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The interferon regulatory factors and oncogenesis.
    Tanaka N; Taniguchi T
    Semin Cancer Biol; 2000 Apr; 10(2):73-81. PubMed ID: 10936058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2.
    Harada H; Kitagawa M; Tanaka N; Yamamoto H; Harada K; Ishihara M; Taniguchi T
    Science; 1993 Feb; 259(5097):971-4. PubMed ID: 8438157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor.
    Li M; Lee H; Guo J; Neipel F; Fleckenstein B; Ozato K; Jung JU
    J Virol; 1998 Jul; 72(7):5433-40. PubMed ID: 9620998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of interferon regulatory factors in the cardiac response to viral infection.
    Sherry B
    Viral Immunol; 2002; 15(1):17-28. PubMed ID: 11952139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein-protein and DNA-protein interactions affect the activity of lymphoid-specific IFN regulatory factors.
    Meraro D; Hashmueli S; Koren B; Azriel A; Oumard A; Kirchhoff S; Hauser H; Nagulapalli S; Atchison ML; Levi BZ
    J Immunol; 1999 Dec; 163(12):6468-78. PubMed ID: 10586038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.